FDA Talks Up Continuous Manufacturing, Offers Assistance

It is time for drug makers to embrace continuous manufacturing methods, CDER Director Janet Woodcock and other FDA officials emphasize. Now the agency is offering additional support to help manufacturers move away from batch processes.

More from Manufacturing

More from Compliance